Please Wait
Applying Filters...
menu
    • menu
    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Cemiplimab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Regeneron lays out bright future for newest blockbuster Libtayo
    Regeneron lays out bright future for newest blockbuster Libtayo

    05 Feb 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/regenerons-libtayo-reaches-blockbuster-status-and-has-potential-more-growth

    FIERCE PHARMA
    05 Feb 2025
    Share Share
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer
    MAIA Biotech Announces Positive Data for THIO-101 in Lung Cancer

    04 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250204174307/en

    BUSINESSWIRE
    04 Feb 2025
    Share Share
    Adjuvant Libtayo® Improves DFS In High-Risk CSCC In Phase 3 Trial
    Adjuvant Libtayo® Improves DFS In High-Risk CSCC In Phase 3 Trial

    13 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/13/3008232/0/en/Adjuvant-Libtayo-cemiplimab-Significantly-Improves-Disease-Free-Survival-DFS-After-Surgery-in-High-Risk-Cutaneous-Squamous-Cell-Carcinoma-CSCC-in-Phase-3-Trial.html

    GLOBENEWSWIRE
    13 Jan 2025
    Share Share
    Palleon Pharma GLIMMER-01 E-602 + Cemiplimab Data at SITC
    Palleon Pharma GLIMMER-01 E-602 + Cemiplimab Data at SITC

    08 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241108273263/en

    BUSINESSWIRE
    08 Nov 2024
    Share Share
    MAIA Announces Positive THIO Phase 2 Survival Updates
    MAIA Announces Positive THIO Phase 2 Survival Updates

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910368128/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share
    Regeneron To Highlight Progress At WCLC And ESMO
    Regeneron To Highlight Progress At WCLC And ESMO

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942695/0/en/Regeneron-to-Highlight-Progress-Across-Its-Differentiated-Oncology-Portfolio-and-Pipeline-at-WCLC-and-ESMO.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share